Related Experiment Video
Updated: Feb 18, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Emergence of Bluetongue virus serotype 5 in Sardinia- Italy, 2025
Maurilia Marcacci1, Stefano Cappai2, Andrea Palombieri1
1Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.
Abstract:
Southern Europe, and Italy in particular, has historically been exposed to repeated incursions of orbiviruses, including multiple bluetongue virus (BTV) serotypes and epizootic haemorrhagic disease virus serotype 8. Sardinia, Italy represents a key sentinel location due to its geographic position in the Mediterranean basin. In August 2025, fatal bluetongue cases in sheep were reported in Sardinia during a period of intense BTV circulation in Italy, characterised by widespread outbreaks associated with BTV-3 and BTV-8. These clinical samples tested positive for BTV but could not be serotyped using the available real-time RT-PCR assays. Whole-genome sequencing identified the causative agent as BTV serotype 5 (BTV-5), representing the first detection of this serotype in Europe. The virus was also successfully isolated in cell culture. Segments 2 and 6 showed the highest nucleotide identity with a BTV-5 strain identified in Nigeria in 1982, whereas the rest of the genome seems to be composed by gene segments originating from multiple BTV serotypes circulating in Africa and Europe. At the time of writing, no official reports of BTV-5 circulation were available from Northern Africa; however, during the editorial process, BTV-5 was reported in Tunisia, further supporting the Mediterranean basin as a single interconnected epidemiological ecosystem for orbivirus emergence and spread.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viral Recombination

